DK39585D0 - Hydantoinderivater, fremgangsmaade til fremstilling heraf og medikament indeholdende et saadant derivat - Google Patents

Hydantoinderivater, fremgangsmaade til fremstilling heraf og medikament indeholdende et saadant derivat

Info

Publication number
DK39585D0
DK39585D0 DK39585A DK39585A DK39585D0 DK 39585 D0 DK39585 D0 DK 39585D0 DK 39585 A DK39585 A DK 39585A DK 39585 A DK39585 A DK 39585A DK 39585 D0 DK39585 D0 DK 39585D0
Authority
DK
Denmark
Prior art keywords
derivative
procedures
preparing
hydantoin derivatives
medicinals containing
Prior art date
Application number
DK39585A
Other languages
English (en)
Other versions
DK158668C (da
DK39585A (da
DK158668B (da
Inventor
Norio Minami
Masayuki Mathukura
Koichiro Ueda
Satoru Tanaka
Toshiji Igarashi
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of DK39585D0 publication Critical patent/DK39585D0/da
Publication of DK39585A publication Critical patent/DK39585A/da
Publication of DK158668B publication Critical patent/DK158668B/da
Application granted granted Critical
Publication of DK158668C publication Critical patent/DK158668C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK039585A 1984-01-30 1985-01-29 Hydantoinderivater, medikament indeholdende et saadant derivat, og anvendelse af et saadant derivat til fremstilling af et antiarrhytmisk medikament DK158668C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1344284 1984-01-30
JP59013442A JPS60158190A (ja) 1984-01-30 1984-01-30 ヒダントイン誘導体およびその製法ならびにそれを含有する医薬

Publications (4)

Publication Number Publication Date
DK39585D0 true DK39585D0 (da) 1985-01-29
DK39585A DK39585A (da) 1985-07-31
DK158668B DK158668B (da) 1990-07-02
DK158668C DK158668C (da) 1990-11-26

Family

ID=11833246

Family Applications (1)

Application Number Title Priority Date Filing Date
DK039585A DK158668C (da) 1984-01-30 1985-01-29 Hydantoinderivater, medikament indeholdende et saadant derivat, og anvendelse af et saadant derivat til fremstilling af et antiarrhytmisk medikament

Country Status (23)

Country Link
US (1) US4650798A (da)
JP (1) JPS60158190A (da)
KR (1) KR870001681B1 (da)
AU (1) AU585207B2 (da)
BE (1) BE901591A (da)
CA (1) CA1249271A (da)
CH (1) CH662354A5 (da)
DE (1) DE3503074A1 (da)
DK (1) DK158668C (da)
ES (2) ES8605523A1 (da)
FI (1) FI83873C (da)
FR (1) FR2558835B1 (da)
GB (1) GB2155466B (da)
HU (1) HU194885B (da)
IE (1) IE850136L (da)
IT (1) IT1184144B (da)
MX (1) MX160579A (da)
NL (1) NL8500248A (da)
NZ (1) NZ210979A (da)
PH (1) PH21920A (da)
SE (1) SE462849B (da)
SU (3) SU1468424A3 (da)
ZA (1) ZA85655B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2708507B2 (ja) * 1988-04-07 1998-02-04 株式会社三和化学研究所 (d)‐6‐フルオロ‐2,3‐ジヒドロ‐2’,5’‐ジオキソ‐スピロ[4H‐1‐ベンゾピラン‐4,4’‐イミダゾリジン]‐2‐カルボキサミド誘導体、これらの製法及び用途
EP0347733A1 (en) * 1988-06-20 1989-12-27 Eisai Co., Ltd. Optically active hydantoin derivatives
US5206240A (en) * 1989-12-08 1993-04-27 Merck & Co., Inc. Nitrogen-containing spirocycles
IL96507A0 (en) * 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
US5382587A (en) * 1993-06-30 1995-01-17 Merck & Co., Inc. Spirocycles
US5403846A (en) * 1993-11-22 1995-04-04 Merck & Co., Inc. Spirocycles
US5439914A (en) * 1994-02-18 1995-08-08 Merck & Co., Inc. Spirocycles
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2455046A1 (fr) * 1979-04-25 1980-11-21 Science Union & Cie Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament

Also Published As

Publication number Publication date
GB2155466B (en) 1987-10-07
DE3503074A1 (de) 1985-08-08
SE8500387D0 (sv) 1985-01-28
JPS60158190A (ja) 1985-08-19
SU1468424A3 (ru) 1989-03-23
ZA85655B (en) 1985-08-28
ES539942A0 (es) 1986-03-16
GB2155466A (en) 1985-09-25
DK158668C (da) 1990-11-26
JPH0441149B2 (da) 1992-07-07
ES8605523A1 (es) 1986-03-16
KR850005442A (ko) 1985-08-26
FI83873C (fi) 1991-09-10
NZ210979A (en) 1987-05-29
IT8519296A0 (it) 1985-01-30
HU194885B (en) 1988-03-28
ES8606293A1 (es) 1986-04-16
PH21920A (en) 1988-04-08
FR2558835A1 (fr) 1985-08-02
ES548960A0 (es) 1986-04-16
SE8500387L (sv) 1985-07-31
IE850136L (en) 1985-07-30
SE462849B (sv) 1990-09-10
SU1609453A3 (ru) 1990-11-23
DK39585A (da) 1985-07-31
FR2558835B1 (fr) 1990-05-18
AU3806285A (en) 1985-08-08
CH662354A5 (fr) 1987-09-30
DK158668B (da) 1990-07-02
BE901591A (fr) 1985-07-29
AU585207B2 (en) 1989-06-15
US4650798A (en) 1987-03-17
MX160579A (es) 1990-03-27
GB8502308D0 (en) 1985-02-27
NL8500248A (nl) 1985-08-16
KR870001681B1 (ko) 1987-09-22
FI850302L (fi) 1985-07-31
CA1249271A (en) 1989-01-24
FI83873B (fi) 1991-05-31
HUT38646A (en) 1986-06-30
IT1184144B (it) 1987-10-22
FI850302A0 (fi) 1985-01-23
SU1445559A3 (ru) 1988-12-15

Similar Documents

Publication Publication Date Title
DK381485A (da) 1,2-benzisothiazol-3-yl-piperazinderivater og fremgangsmaade til fremstilling deraf
DK356485D0 (da) Pyridinderivater og fremgangsmaade til fremstilling deraf
DK577084D0 (da) 2,2'iminobisethanol-derivater og fremgangsmaade til fremstilling deraf
DK371384A (da) Substituerede benzylalkoholderivater og fremgangsmaade til fremstilling deraf
DK468284D0 (da) 1,2,4-triazolonderivater og fremgangsmaade til fremstilling deraf
DK8088A (da) Heteroaryl 3-oxo-propannitril-derivater og fremgangsmaade til fremstilling deraf
DK507084D0 (da) Hydroxybenzenderivater, fremgangsmaade til fremstilling heraf og farmaceutisk praeparat indeholdende et saadant derivat
DK435588D0 (da) Aralkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende disse
DK305884D0 (da) Phenoxyderivat, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
DK39585D0 (da) Hydantoinderivater, fremgangsmaade til fremstilling heraf og medikament indeholdende et saadant derivat
DK165952C (da) 1,3-oxazolidin-2-on-derivater og fremgangsmaade til fremstilling heraf
DK375085A (da) Quinolon-carboxylsyre-derivater og fremgangsmaade til fremstilling deraf
DK357385A (da) Dihydropyridin-derivater og fremgangsmaade til fremstilling deraf
DK291088A (da) Tetrehydrofuran- og tetrahydrothiophen-derivater, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne derivater
DK313785D0 (da) Dihydroorotsyrederivat og fremgangsmaade til fremstilling deraf
DK291188D0 (da) 5-methoxyalkylammonium-tetrahydrofuran- og -tetrahydrothiophen-derivater, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne derivater
DK164787C (da) 3-substituerede pyrazolooe1,5-aaapyridinderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
DK401385A (da) 7-oxomitosan-derivater og fremgangsmaade til fremstilling deraf
DK487688A (da) Benzofuranderivater og fremgangsmaade til fremstilling deraf
DK446685D0 (da) Carbapenemderivater og fremgangsmaade til fremstilling deraf
DK624588A (da) 4-demethoxy-anthracyclin-derivater og fremgangsmaade til fremstilling deraf
DK402885D0 (da) 1,3-dihydro-6-aminomethyl-7-hydroxy-furo-(3,4-c)-pyridin-derivater, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne forbindelser
DK182585D0 (da) Fosfomycinderivat og fremgangsmaade til fremstilling deraf
DK160832C (da) Heterocycliske bornan-derivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende saadanne forbindelser
DK381986A (da) 1,5-benzodioxepanderivater, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne forbindelser

Legal Events

Date Code Title Description
PBP Patent lapsed